{"name":"Patrick Wen, MD","slug":"patrick-wen-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQX0wzcUhpbHcyZ29kT1o5Z0FSU1M0dlBneGVTLThUc0hjUlI0Tk01amRLTnhRNWo5cF9udkFVTTl0LU8wZUhDTk9hSkZfVWx5b0s3LW04WU1LVlNIOHJSeXBXZGZNcVB2NEpnUTU5ZGNqNjN5WUNadjh3cUQyLS15a1BZNWYzanBUVmt0VWJfREFZalh1c3I5Q2oyZTd5emluMXRNZlJudGFKNGxkRDczVFNkREp4MlNSb3UtSQ?oc=5","date":"2025-08-27","type":"regulatory","source":"The Healthcare Technology Report.","summary":"Jazz Pharmaceuticals Wins FDA Approval for Modeyso Recurrent Glioma Treatment - The Healthcare Technology Report.","headline":"Jazz Pharmaceuticals Wins FDA Approval for Modeyso Recurrent Glioma Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxObHhTU0ZDX2RIVkRBZHNQSElnVGhEMldPZTkyRlg0MldiYXREQjZPamhMQ0JmaFRpVW5lbEpQUXU3dVkxdFBZVFBZUDJHSGYzcWFSY21BOHlUcm1TVk5yS0xEYW43cHYyalAtXy1Wd3pfQUVySG5xazB0eVpxcHltelhibVNVWFdTT0VuNlBYMHNfa2tuMTZrblF4QXY?oc=5","date":"2025-08-08","type":"regulatory","source":"Brain Tumour Research","summary":"First drug approved for diffuse midline glioma - Brain Tumour Research","headline":"First drug approved for diffuse midline glioma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxNZW16TEhnRm9XdFVkUzFINkVGbk9RNnByX2ZpNHUxRHRyVXVxUzVHSXFJQ1oySlRhSFZmM09qSEhaZFA4VGw3WU1oalg0bks4NlpWa0RZM0dKRjA0VGdXOGtPY0ViRGRmd05qTnQwZUozOGRKRDlTOUctaHJqZkhQbGVrUC1kMFJYYTI1M1locThFcmZkcTBxNDNqRzFlVGN0ei0zcHA5QkpIb2hZakNiOHRwOXhLLVkxOHhqZDVOZWVaSWpjcUFGc2xWVWFVRFRKS0VKNm9PR1RuTkxXT09YdGY4dmhkc0RZMEhDWW03RU95X0RGa2xfQTQyVWV0WWp3R0FVZWZxU29yRThITDhSRG1YeFptTFZQV2Fqa185VzhWWXljd2s3QUh4ZDZ6dHRLV0JqSA?oc=5","date":"2025-08-06","type":"regulatory","source":"PR Newswire","summary":"Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma - PR Newswire","headline":"Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurren","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9PRThlZ1drUUpVTGIwZ3pIZ1VDS2tiR2tibXZjM3lpYmJfcF9TVUtJYktta1hZX1RnVWUzWkFPazN2NkRXX1NHMVFJTWJPMkRHNjY4U3FCSlNBVFlMZXU0aDhqdlg1alhTdlI0ZHFjSjVOdW53?oc=5","date":"2025-08-06","type":"regulatory","source":"MedPage Today","summary":"FDA Approves Brain Tumor Drug Targeting New Mutation - MedPage Today","headline":"FDA Approves Brain Tumor Drug Targeting New Mutation","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNcHVjMHhFTC13TE0wT0Rlc3pnLWUxbm5GekVFWDE1Q01tNjB0WVUtVXRqNlRDcWtDV2h2U1Azd3FiYy05MTV5Xzk1YzI0QWNaRWdXVTI2UUR6b1pGNzNTUWg0MURaMFlFOUxxRG03ajFuLUVaSklwckEyY3RocjNWR1U0cVJxYW1fRmotZHRESDJFV2lQTVg3LTV6bVV3bG5fWEVPWnJfanQ4Ykh6T0E?oc=5","date":"2025-08-06","type":"regulatory","source":"ajmc.com","summary":"FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma - ajmc.com","headline":"FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOODF0OG9iTFpxU3B2aXhBX0Z0eW4yWXF3T0VNYmlxYnRGUzNMd29zN095bmlUNkw3dTZ0clBsWjZTa1NwWXZXV0EyQ1VpS0dUY2tnMVBSS3FfQkpnX2ZYX0Z3c3BNdU8zWmRYVEdYdTc5ZkNxSDFwdzR3N01FaE5JZzFRaTdFQ1lsNEU2aTRxWUd0ckJUSTZLd0RIV205VHFUTHBOdXlmcHFaRzd4bmJkMlE5N2FabmdrenhuMmhGLUxVdlZX?oc=5","date":"2024-11-22","type":"trial","source":"The ASCO Post","summary":"Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor - The ASCO Post","headline":"Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE8xNXk2cEVPbl9Fb2ZCandwOWhNOTFUcjllbmRwTnFoTlNCenJGOE0zcUtiQXpsRW9fRkNDYmdjNVZxWGozbWlzYVI2MUVlbGFZQlpiUzVXSQ?oc=5","date":"2022-04-16","type":"pipeline","source":"EurekAlert!","summary":"Patrick Wen, MD (IMAGE) - EurekAlert!","headline":"Patrick Wen, MD (IMAGE) - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPUDkyaWNGbUFrSmxRdUxGb0NDaUxaVExsTFhjMXhCQjRIVFBXbkx4bWp5dTJWRk05dDByMkE3XzZHcXRwX1dmSmlJRElzZzdkTl9yMmpwU3k3TmNDc0xaNGRTMERVMExVbmdhU0dqRE90WVdYVDlSN193UTBHaEhCX041NlZnOW8?oc=5","date":"2022-03-30","type":"pipeline","source":"OncLive","summary":"Targeted Combo Notches Rare Success in Glioblastoma - OncLive","headline":"Targeted Combo Notches Rare Success in Glioblastoma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}